KPC Pharmaceuticals (SHSE:600422) Short Interest


SHSE:600422 KPC Pharmaceuticals Inc SHSE:600422
62 GF Score
Price ¥8.05
GF Value ¥11.77
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is KPC Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


SHSE:600422 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, KPC Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KPC Pharmaceuticals Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, KPC Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where KPC Pharmaceuticals's Short Interest falls into.


SHSE:600422
62GF Score
KPC Pharmaceuticals Inc SHSE:600422
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is KPC Pharmaceuticals (SHSE:600422) Overvalued in 2026?

Based on GuruFocus' analysis, KPC Pharmaceuticals stock appears to be undervalued. The current stock price of ¥8.05 is trading 31.6% below its estimated GF Value™ of ¥11.77. GuruFocus considers KPC Pharmaceuticals to be Significantly Undervalued.

Key valuation signals for SHSE:600422:

  • Short Interest:
  • GF Value™: ¥11.77 vs. price of ¥8.05 (31.6% below fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the SHSE:600422 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


KPC Pharmaceuticals Business Description

Address No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
62GF Score

Get the complete analysis for SHSE:600422

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.05
Price
¥11.77
GF Value